Citations - Raspagliesi Francesco

CONCLUSIONS: Our report highlights that COVID-19 impacts the quality of treatments for cancer patients. Mortality rate is high, especially after surgery. More important, patients under active treatment for cancer are at high risk of developing severe evolution of COVID-19. Prioritizing patients journey during COVID-19 is of paramount importance.... Read more
Published on: 2020-06-15
Source: Raspagliesi Francesco
By: Giorgio Bogani
CONCLUSIONS: Our report highlights that COVID-19 impacts the quality of treatments for cancer patients. Mortality rate is high, especially after surgery. More important, patients under active treatment for cancer are at high risk of developing severe evolution of COVID-19. Prioritizing patients journey during COVID-19 is of paramount importance.... Read more
Published on: 2020-06-15
Source: Raspagliesi Francesco
By: Giorgio Bogani
CONCLUSIONS: Our report highlights that COVID-19 impacts the quality of treatments for cancer patients. Mortality rate is high, especially after surgery. More important, patients under active treatment for cancer are at high risk of developing severe evolution of COVID-19. Prioritizing patients journey during COVID-19 is of paramount importance.... Read more
Published on: 2020-06-15
Source: Raspagliesi Francesco
By: Giorgio Bogani
CONCLUSIONS: Our report highlights that COVID-19 impacts the quality of treatments for cancer patients. Mortality rate is high, especially after surgery. More important, patients under active treatment for cancer are at high risk of developing severe evolution of COVID-19. Prioritizing patients journey during COVID-19 is of paramount importance.... Read more
Published on: 2020-06-15
Source: Raspagliesi Francesco
By: Giorgio Bogani
CONCLUSIONS: Our report highlights that COVID-19 impacts the quality of treatments for cancer patients. Mortality rate is high, especially after surgery. More important, patients under active treatment for cancer are at high risk of developing severe evolution of COVID-19. Prioritizing patients journey during COVID-19 is of paramount importance.... Read more
Published on: 2020-06-15
Source: Raspagliesi Francesco
By: Giorgio Bogani
CONCLUSIONS: Our report highlights that COVID-19 impacts the quality of treatments for cancer patients. Mortality rate is high, especially after surgery. More important, patients under active treatment for cancer are at high risk of developing severe evolution of COVID-19. Prioritizing patients journey during COVID-19 is of paramount importance.... Read more
Published on: 2020-06-15
Source: Raspagliesi Francesco
By: Giorgio Bogani
Ovarian cancer is characterized by a high mortality on incidence ratio. Although the majority of patients achieve complete response after primary treatment, approximately 65-80% of patients recur with the first 5 years. Platinum-free interval is one of the main prognostic factors. Patients recurring with 6 months within the end of... Read more
Published on: 2020-06-11
Source: Raspagliesi Francesco
By: Giorgio Bogani
CONCLUSIONS: The data show that primary conization might overcome the risk of local recurrence after laparoscopic radical hysterectomy in early stage cervical cancer. Further prospective evidence is needed.... Read more
Published on: 2020-06-09
Source: Raspagliesi Francesco
By: Giorgio Bogani
No abstract... Read more
Published on: 2020-06-05
Source: Raspagliesi Francesco
By: Giorgio Bogani
At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on... Read more
Published on: 2020-06-02
Source: Raspagliesi Francesco
By: Giorgio Bogani
  • Other

    Citations

  • Other

    Citations

Translate »